captopril has been researched along with Left Ventricular Hypertrophy in 118 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 71 (60.17) | 18.2507 |
2000's | 37 (31.36) | 29.6817 |
2010's | 9 (7.63) | 24.3611 |
2020's | 1 (0.85) | 2.80 |
Authors | Studies |
---|---|
Hasmono, D; Hijriani, N; Yusetyani, L | 1 |
Arsenault, M; Couet, J; Dhahri, W; Drolet, MC; Gascon, S; Grenier, A; Lecomte, R; Rousseau, JA; Roussel, E; Sarrhini, O; Zendaoui, A | 1 |
Abdureyim, S; Amat, N; Amat, R; Hoxur, P; Kijjoa, A; Mamut, D; Osman, Z | 1 |
Ding, Z; Ge, J; Gong, H; Jiang, G; Li, Y; Wang, S; Wang, X; Wu, J; Ye, Y; Yin, P; Yuan, J; Zhang, W; Zhou, J; Zou, Y | 1 |
Hagendorff, A; Hawlitschek, C; Rabald, S; Rassler, B; Zimmer, HG; Zimmer, J | 1 |
Dimitrijevic, J; Djukanovic, L; Jovanovic, D; Jovovic, D; Maksic, N; Mihailovic-Stanojevic, N; Miloradovic, Z; Naumovic, R | 1 |
Arsenault, M; Beaudoin, J; Bojmehrani, A; Champetier, S; Couet, J; Lachance, D; Plante, E; Roussel, E | 1 |
Jendekova, L; Paulis, L; Pechanova, O; Simko, F; Sladkova, M; Vranková, S | 1 |
Adamcova, M; Bednarova, K; Krajcirovicova, K; Mullerova, M; Paulis, L; Pechanova, O; Pelouch, V; Simko, F | 1 |
Arsenault, M; Beaudoin, J; Champetier, S; Couet, J; Lachance, D; Plante, E; Roussel, E | 1 |
Folino, A; Merlino, A; Moro, F; Pagliaro, P; Penna, C; Tullio, F | 1 |
Ouyang, JP; Wang, CH; Wei, L | 1 |
Duan, HJ; He, LC; Zhan, YZ; Zhang, Y | 1 |
Babál, P; Hlavačková, L; Janega, P; Pecháňová, O; Vranková, S | 1 |
Ebina, T; Hibi, K; Kimura, K; Kosuge, M; Kusama, I; Morita, S; Nozawa, N; Okuda, J; Ozaki, H; Tsukahara, K; Umemura, S; Yano, H | 1 |
Hsieh, YM; Huang, CY; Kuo, WW; Lin, CC; Lin, PP; Tsai, CC; Tsai, CH; Tsai, FJ | 1 |
Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C | 1 |
Wang, S; Wang, SR; Zhao, YR | 1 |
Prado, CM; Ramos, SG; Rossi, MA | 1 |
Akimoto, K; Minamino, N; Mori, Y; Nishikimi, T; Tadokoro, K; Wang, X | 1 |
Lapointe, N; Pourdjabbar, A; Rouleau, JL | 1 |
Goens, MB; Kanagy, NL; Lund, AK; Walker, MK | 1 |
Saxena, PR; Schoemaker, RG; Van Kerckhoven, R; van Veghel, R | 1 |
Arsenault, M; Couet, J; Drolet, MC; Gaudreau, M; Gauthier, C; Lachance, D; Lapointe, E; Plante, E; Roussel, E | 1 |
Brigstock, DR; Carretero, OA; Cavasin, MA; Peng, H; Rasoul, S; Rhaleb, NE; Sanchez-Mendoza, A; Zhuo, J | 1 |
Buikema, H; de Zeeuw, D; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
Anavekar, NS; Arnold, JM; Barvik, S; Bourgoun, M; Califf, RM; Ghali, JK; Khrakovskaya, M; McMurray, JV; Pfeffer, MA; Schwartz, Y; Skali, H; Solomon, SD; Velazquez, EJ; Warnica, JW | 1 |
Buikema, H; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
de Lanerolle, P; Gu, LZ; Han, YJ; Hu, WY; Piano, M | 1 |
Brower, GL; Janicki, JS; Levick, SP | 1 |
Jendeková, L; Kojsová, S; Pechánová, O; Sládková, M | 1 |
Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T | 1 |
Anthanázio-Heliodoro, Rde C; Brandão-Neto, J; de Barros e Silva, M; Franco RJ da, S; Marchioli, M; Martin, LC; Velasco-Cornejo, IF | 1 |
Baldwin, KM; Bodell, PW; Haddad, F | 1 |
Bao, YD; Chen, DG; Chen, SC; Jing, XQ; Lin, YQ; Wang, HJ | 1 |
Xu, SC; Zhang, YH | 1 |
Kanno, M; Kitabatake, A; Kohya, T; Nakaya, H; Saito, H; Tohse, N; Yokoshiki, H | 1 |
Kingma, JH; Pinto, YM; Schunkert, H; van Gilst, WH | 1 |
Jugdutt, BI | 1 |
Bao, YD; Chen, DG; Chen, SC | 1 |
Atanacković, D; Dodić, S; Pavlović, K | 1 |
Connors, KF; Lamas, GA | 1 |
Blinston, GE; Jugdutt, BI; Jugdutt, SJ; Khan, MI | 1 |
Basta, L; Braunvald, Iu; Dévis, BR; Fleĭker, GS; Geltman, EM; Goldman, S; Kaddi, TE; Moĭe, LA; Pfeffer, MA | 1 |
Bachmann, K; Engels, G; Gellert, J; Henneke, KH; Machnig, T; Pongratz, G; Schmalzl, M | 1 |
Carlyle, PF; Cohn, JN; Francis, GS; McDonald, KM; Rector, T | 1 |
Díez, J; Laviades, C | 1 |
Guo, X; Guo, ZG; Ling, Q; Su, Z | 1 |
Chen, DG; Chen, HJ; Wang, HJ; Xie, LD; Zhang, S | 1 |
Hoyos Jiménez, M; Justo Alpañes, E; Moreno Alba, R; Olivan Martínez, J; Pérez Cano, R | 1 |
Arnold, JM; Davis, BR; Dinh, H; Farnham, DJ; Geltman, E; Hayes, D; Moyé, LA; Pfeffer, MA; Randall, OS; Wun, CC | 1 |
Yokoshiki, H | 1 |
Pfeffer, MA | 1 |
Bertossi, M; Nico, B; Pirrelli, A; Ricci, S; Roncali, L; Seccia, T; Vulpis, V | 2 |
Cohn, PF; Jain, P; Korlipara, G; Lillis, O; Mallavarapu, C; Sikand, V | 1 |
Abugov, SA; Arabidze, GG; Bekzhigitov, SB; Savchenko, AP; Shapkina, LS; Smirnov, AA | 1 |
Díez, J; Laviades, C; Mayor, G | 2 |
Gøtzsche, CO; Nøgaard, A; Ravkilde, J; Søgaard, P; Thygesen, K | 1 |
Dagenais, GR; Goldman, S; Klein, M; Lamas, GA; Moyé, LA; Pfeffer, MA; Plappert, T; Rouleau, JL; St John Sutton, M; Sussex, B | 1 |
Kato, Y; Mizota, M; Shinkawa, T; Tsuchiya, N; Uemura, A; Yamasaki, F | 1 |
Bélichard, P; Cardinal, R; Gosselin, H; Nadeau, R; Paradis, P; Rouleau, JL; Savard, P | 1 |
Ganley, CJ; Hung, HM; Temple, R | 1 |
Campos-Peris, JV; Canton-Martinez, A; Castillo-Soria, FJ; Galcera-Tomas, J; Nuño de la Rosa, JA; Pico-Aracil, F; Rodriguez-Garcia, P; Ruiperez-Abizanda, JA; Ruiz-Ros, JA; Torres-Martinez, G | 1 |
Abe, M; Haneda, T; Okamoto, K | 1 |
Mukherjee, D; Sen, S | 1 |
Clark, RG; Gillett, N; Jin, H; Ko, A; Paoni, NF; Yang, R | 1 |
Bendel-Stenzel, M; Najarian, JS; Sinaiko, AR | 1 |
Ganguly, NK; Ghosh, S; Reddy, DS; Singh, M | 1 |
Di Legge, V; Ghiadoni, L; Lucarini, A; Salvetti, A; Taddei, S; Virdis, A | 1 |
Berglund, G; Boström, PA; Diemer, H; Lilja, B; Mansour, P; Mattiasson, I; Nehoum, A | 1 |
Dambrink, JH; Kingma, JH; Peels, KH; St John Sutton, M; van Gilst, WH | 1 |
Bernátová, I; Pechánová, O; Simko, F | 1 |
Dalton, GR; Evans, SJ; Jones, JV; Levi, AJ | 1 |
Anderson, RJ; Gottdiener, JS; Massie, BM; Materson, BJ; Reda, DJ; Williams, DW | 1 |
Hiwada, K; Ito, T; Joh, T; Muneta, S; Ochi, T; Sumimoto, T | 1 |
Bagriy, AE; Dyadyk, AI; Lebed, IA; Schukina, EV; Taradin, GG; Yarovaya, NF | 1 |
Kanno, M; Kitabatake, A; Kohya, T; Nakaya, H; Tohse, N; Tomita, F; Yokoshiki, H | 1 |
Carraro, A; Crepaldi, G; Fasoli, G; Frigato, F; Marin, M; Nisti, S; Nosadini, R; Palisi, M; Scognamiglio, R; Virgili, F | 1 |
Jugdutt, BI; Khan, MI; Lucas, A | 1 |
Filart, RA; Kowey, PR; Marinchak, RA; Rials, SJ; Wu, Y; Xu, X | 1 |
Bagriĭ, AE; Diadyk, AI; Diadyk, IA; Gaĭdukov, VO; Gritsenko, PV; Iarovaia, NF; Lebed', IA; Shchukina, EV | 1 |
Brandt, D; Hofmann, R; Magometschnigg, D; Sihorsch, K; Stoschitzky, K; Zangeneh, M; Zenker, G | 1 |
Bhambhani, A; Ford, WR; Jugdutt, BI; Khan, MI; Liyanage, R; Menon, V | 1 |
Bernátová, I; Pechánová, O; Pelouch, V; Simko, F | 2 |
Krakoff, LR; Rajasekharaiah, V | 1 |
Daemen, MJ; Smits, JF; van Suylen, RJ | 1 |
Humen, DP; Jugdutt, BI | 1 |
Bada, V; Bernátová, I; Gvozdjáková, A; Hulín, I; Kucharská, J; Pechánová, O; Simko, F; Turcáni, M | 1 |
Kowey, PR; Marinchak, RA; Rials, SJ; Wu, Y; Xu, X | 1 |
Li, HY; Pan, JY; Zheng, H; Zhou, XN | 1 |
Bichet, D; Ciampi, A; de Champlain, J; Harel, F; Moyé, LA; Pfeffer, M; Rouleau, JL; Vantrimpont, P | 1 |
Chen, DG; Chen, SC; Hu, WY; Jin, XQ; Wang, HJ | 1 |
Chen, TH; Guo, ZG; Ling, Q | 1 |
Bada, V; Braunova, Z; Gvozdjakova, A; Kucharska, J; Kyselovic, J; Simko, F | 1 |
Chen, DG; Chen, SC; Hu, WY; Rui, HB; Su, JZ; Wang, HJ; Wang, XY; Wu, KG; Xu, CS | 1 |
Colado, MI; Delgado, C; Fernández-Tomé, P; López-Miranda, V; Martínez, ML | 1 |
Chen, X; Guan, JX; Luo, JD; Zhang, GP; Zhang, WW | 1 |
Kowey, PR; Liu, T; Marinchak, RA; Rials, SJ; Wu, Y; Xu, X | 1 |
Itoh, K; Itoh, Y; Kitabatake, A; Kohya, T; Mochizuki, T; Ono, T; Tamaki, N; Tomita, F; Tsukamoto, E | 1 |
MacCarthy, PA; Shah, AM | 1 |
Brilla, CG | 1 |
Hata, A; Ikeda, Y; Kimura, H; Mochizuki, S; Nakamura, T; Obata, JE; Shido, K; Takano, H; Takeda, S; Yoshida, Y | 1 |
Dalton, GR; Jones, JV; Levi, AJ; Levy, A | 1 |
Chung, ES; Lancaster, EJ; Mela, T; Meyer, TE; Norton, GR; Sprott, S; Tsotetsi, OJ; Woodiwiss, AJ | 1 |
Bravo, R; Fernández-Alfonso, MS; González, C; Ruiz-Gayo, M; Somoza, B | 1 |
Bravo, R; Fernández-Alfonso, MS; González, C; Ruilope, LM; Ruiz-Gayo, M; Somoza, B | 1 |
Isaksson, H; Kahan, T; Malmqvist, K; Ostergren, J | 1 |
Hansson, L; Hedner, T; Himmelmann, A | 1 |
Ando, H; Fujimaki, R; Hatano, S; Miyake, F; Nagashima, J; Nobuoka, S; Saito, K; Tokuoka, S | 1 |
Al-Shafei, AI; Bronns, G; Carpenter, TA; Gresham, GA; Hall, LD; Huang, CL; Wise, RG | 1 |
Kesavarao, U; Sharma, JN | 1 |
Kyselovic, J; Pelouch, V; Simko, F | 1 |
Campa, PP; Collatina, S; Gaudio, C; Pagnotta, P; Paknejad, K; Tanzilli, G | 1 |
Doering, W; Kleber, FX; Niemöller, L; Nussberger, J | 1 |
Barzizza, F; Crea, G; Magnani, L; Richichi, I | 1 |
2 review(s) available for captopril and Left Ventricular Hypertrophy
Article | Year |
---|---|
Postmyocardial infarction patients: experience from the SAVE trial.
Topics: Captopril; Decision Trees; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 1995 |
Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Renin-Angiotensin System | 1998 |
25 trial(s) available for captopril and Left Ventricular Hypertrophy
Article | Year |
---|---|
Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Chi-Square Distribution; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hypertrophy, Left Ventricular; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Predictive Value of Tests; Prospective Studies; Renin-Angiotensin System; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Valine; Valsartan | 2012 |
[Study on effect of jiangya tongmai recipe on vascular activating substances in patients of hypertension with left ventricular hypertrophy].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Calcitonin Gene-Related Peptide; Captopril; Drugs, Chinese Herbal; Endothelins; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Phytotherapy; Ventricular Function, Left | 2002 |
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Hospitalization; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Stroke Volume; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
[Arterial hypertension in obese patients with heart hypertrophy. Effects of captopril on insulin sensitivity and growth hormone].
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Captopril; Female; Glucose Intolerance; Glucose Tolerance Test; Growth Hormone; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Obesity; Time Factors | 1995 |
Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators.
Topics: Alleles; Captopril; Double-Blind Method; Female; Follow-Up Studies; Gene Deletion; Homozygote; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Peptidyl-Dipeptidase A; Prospective Studies; Streptokinase; Thrombolytic Therapy; Time Factors; Ultrasonography | 1995 |
[Echocardiographic evaluation of the effect of treatment with captopril in patients with essential hypertension].
Topics: Adult; Captopril; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male | 1994 |
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Captopril; Cardiac Output, Low; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Morbidity; Myocardial Infarction; Prognosis; Recurrence; Risk Factors; Stroke Volume; Survival Rate; Time Factors; Ventricular Function, Left | 1993 |
Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Circadian Rhythm; Drug Combinations; Echocardiography; Female; Fourier Analysis; Heart Rate; Heart Septum; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nitrendipine; Ventricular Function, Left | 1994 |
Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Isoquinolines; Lisinopril; Male; Middle Aged; Myocardium; Quinapril; Tetrahydroisoquinolines | 1994 |
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study.
Topics: Captopril; Cohort Studies; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Hypertrophy, Left Ventricular; Life Tables; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1994 |
The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
Topics: Adult; Aged; Captopril; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Proportional Hazards Models; Survival Rate; Ventricular Function, Left | 1993 |
Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction.
Topics: Captopril; Cardiac Volume; Double-Blind Method; Electrocardiography; Female; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Recurrence; Ultrasonography; Ventricular Function, Left | 1994 |
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
Topics: Captopril; Echocardiography; Female; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Time Factors; Ventricular Function, Left | 1994 |
Effects of early use of captopril on haemodynamics and short-term ventricular remodelling in acute anterior myocardial infarction.
Topics: Acute Disease; Adult; Aged; Captopril; Double-Blind Method; Heart Ventricles; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Middle Aged; Myocardial Infarction; Time Factors; Treatment Outcome; Ventricular Function, Left | 1993 |
Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment.
Topics: Acetylcholine; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Circulation; Dipyridamole; Echocardiography; Electrocardiography; Female; Forearm; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Microvascular Angina; Middle Aged; Vascular Resistance | 1996 |
Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy; Time Factors; Treatment Outcome | 1996 |
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Captopril; Clonidine; Cohort Studies; Diltiazem; Diuretics; Double-Blind Method; Echocardiography; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Organ Size; Prazosin; Prevalence; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; United States; United States Department of Veterans Affairs | 1997 |
Both a calcium antagonist and ACE inhibitor reverse hypertrophy in hypertension but a calcium antagonist also depresses contractility.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Contraction; Nicardipine; Ventricular Function, Left | 1997 |
ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diastole; Drug Tolerance; Enalapril; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Single-Blind Method; Systole; Ventricular Function, Left | 1997 |
Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evaluation; Drug Tolerance; Echocardiography; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nitrendipine; Stroke Volume; Treatment Outcome | 1997 |
Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Verapamil | 1997 |
Limitation of left ventricular hypertrophy and dysfunction by ACE inhibition after anterior Q-wave myocardial infarction.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Double-Blind Method; Echocardiography; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Ultrasonography, Doppler; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Female; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prognosis; Prospective Studies; Renin; Survival Rate | 1998 |
Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Echocardiography; Female; Humans; Hypertrophy, Left Ventricular; Insulin; Insulin Resistance; Lipids; Male; Metoprolol; Middle Aged | 2001 |
Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
Topics: Atrial Natriuretic Factor; Captopril; Cardiac Catheterization; Cardiac Volume; Double-Blind Method; Epinephrine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prospective Studies; Renin-Angiotensin System; Ventricular Function, Left | 1992 |
91 other study(ies) available for captopril and Left Ventricular Hypertrophy
Article | Year |
---|---|
The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension.
Topics: Adjuvants, Pharmaceutic; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Curcuma; Enzyme Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; NG-Nitroarginine Methyl Ester; Plant Extracts; Treatment Outcome | 2020 |
Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Captopril; Disease Models, Animal; Echocardiography; Energy Metabolism; Extracellular Matrix; Fatty Acids; G-Protein-Coupled Receptor Kinase 5; Hypertrophy, Left Ventricular; Myocardium; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Rats; Severity of Illness Index; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Aqueous extract of dioscorea opposita thunb. normalizes the hypertension in 2K1C hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Captopril; China; Dioscorea; Drugs, Chinese Herbal; Endothelin-1; Heart; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Kidney; Male; Malondialdehyde; Oxidative Stress; Phytotherapy; Rats, Sprague-Dawley; Rats, Wistar; Superoxide Dismutase | 2014 |
Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Autophagy; Blood Pressure; Captopril; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Drugs, Chinese Herbal; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Metoprolol; Mice, Inbred C57BL; Myocytes, Cardiac; Signal Transduction; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echocardiography; Heart Failure; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Nifedipine; Random Allocation; Rats, Inbred SHR; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Carbazoles; Carvedilol; Creatinine; Disease Models, Animal; Disease Progression; Doxorubicin; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Kidney Failure, Chronic; Propanolamines; Proteinuria; Rats; Rats, Inbred SHR; Time Factors | 2009 |
Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Captopril; Disease Models, Animal; Extracellular Matrix Proteins; Gene Expression Profiling; Gene Expression Regulation; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Metoprolol; Oligonucleotide Array Sequence Analysis; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Time Factors | 2009 |
Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Femoral Artery; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Kidney; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Treatment Outcome | 2009 |
Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Captopril; Hypertrophy, Left Ventricular; Kidney; Male; Melatonin; Mineralocorticoid Receptor Antagonists; NF-kappa B; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Simvastatin; Spironolactone; Ventricular Remodeling | 2009 |
Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Captopril; Cardiomyopathy, Dilated; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography, Doppler; Follow-Up Studies; Hypertrophy, Left Ventricular; Losartan; Male; Nifedipine; Rats; Rats, Wistar; Renin-Angiotensin System; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 2009 |
Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Echocardiography; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2010 |
[c-Fos expression of left ventricular experimental ventricular hypertrophy rats and the effect of cap on it].
Topics: Animals; Captopril; Cardiomegaly; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2001 |
[Effects of Bai-Chuan capsule on left ventricular hypertrophy and correlative indexes].
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Apiaceae; Blood Pressure; Capsules; Captopril; Drugs, Chinese Herbal; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Radioimmunoassay; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2010 |
The effect of indapamide on development of myocardial hypertrophy and fibrosis in L-NAME-induced hypertension in rat.
Topics: Animals; Captopril; Collagen Type I; Collagen Type III; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar | 2011 |
Inhibition of cardiac hypertrophy by probiotic-fermented purple sweet potato yogurt in spontaneously hypertensive rat hearts.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Captopril; gamma-Aminobutyric Acid; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor II; Interleukin-6; Ipomoea batatas; Male; Mitogen-Activated Protein Kinase 7; Natriuretic Peptide, Brain; NFATC Transcription Factors; Organ Size; Protein Kinase C-alpha; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Yogurt | 2012 |
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR | 2002 |
Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Collagen; Disease Models, Animal; Enzyme Inhibitors; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Mitochondria, Heart; Models, Cardiovascular; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Predictive Value of Tests; Randomized Controlled Trials as Topic; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Treatment Outcome | 2003 |
Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic.
Topics: Adrenomedullin; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcitonin Receptor-Like Protein; Captopril; Diuretics; Drug Therapy, Combination; Gene Expression; Hypertension; Hypertrophy, Left Ventricular; Intracellular Signaling Peptides and Proteins; Ligands; Male; Membrane Proteins; Myocardium; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; RNA, Messenger; Sodium Chloride Symporter Inhibitors; Trichlormethiazide; Up-Regulation | 2003 |
The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Captopril; Disease Models, Animal; Echocardiography; Endothelin-1; Genetic Markers; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Receptors, Aryl Hydrocarbon; RNA, Messenger; Ventricular Myosins | 2003 |
Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Capillaries; Captopril; Coronary Circulation; Glucocorticoids; Heart Rate; Hypertrophy, Left Ventricular; Imidazoles; Male; Methylprednisolone; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Wistar; Sympatholytics | 2004 |
Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Fibronectins; Gene Expression; Hypertrophy, Left Ventricular; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2004 |
Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cell Division; Collagen; Connective Tissue Growth Factor; Drug Therapy, Combination; Fibrosis; Growth Inhibitors; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Macrophages; Male; Mast Cells; Monocytes; Myocardium; Myocytes, Cardiac; Oligopeptides; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2004 |
Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Diet, Sodium-Restricted; Heart Ventricles; Hypertrophy, Left Ventricular; In Vitro Techniques; Kidney; Male; Myocardial Infarction; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Ventricular Function, Left | 2004 |
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Creatinine; Drug Therapy, Combination; Heart Ventricles; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Kidney; Kidney Function Tests; Lisinopril; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Prodrugs; Rats; Rats, Sprague-Dawley; Ventricular Function | 2005 |
Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Extracellular Signal-Regulated MAP Kinases; Female; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Arteries; Myosin Light Chains; Phosphorylation; ras Proteins; Rats; Rats, Inbred SHR | 2007 |
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriovenous Shunt, Surgical; Captopril; Compliance; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Lisinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardial Contraction; Myocardium; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Time Factors; Venae Cavae; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2007 |
Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Diuretics; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Femoral Artery; Heart Ventricles; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Indapamide; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2007 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Captopril; Cardiovirus Infections; Enalapril; Encephalomyocarditis virus; Female; Heart; Heart Failure; Hypertrophy, Left Ventricular; Imidazoles; Injections, Intraperitoneal; Losartan; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; Organ Size; Random Allocation; Tetrazoles; Therapeutic Equivalency | 1995 |
Pressure-induced regulation of myosin expression in rodent heart.
Topics: Animals; Aortic Valve Stenosis; Body Weight; Captopril; Desoxycorticosterone; Female; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Myosins; Nephrectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rodentia | 1995 |
Inhibition of left ventricular hypertrophy and expression of proto-oncogenes c-myc other than c-fos in myocardium by early captopril treatment in SHR rats.
Topics: Animals; Captopril; Female; Gene Expression; Hypertrophy, Left Ventricular; Male; Myocardium; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 1995 |
Captopril cardioplegia on myocardial protection in the hypertrophied rat hearts.
Topics: Animals; Captopril; Coronary Circulation; Creatine Kinase; Heart Arrest, Induced; Hypertrophy, Left Ventricular; In Vitro Techniques; Lactates; Lactic Acid; Male; Models, Cardiovascular; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left | 1994 |
Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Body Weight; Captopril; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Organ Size; Rats; Rats, Inbred SHR; Tetrazoles | 1995 |
Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model.
Topics: Animals; Captopril; Collagen; Dogs; Echocardiography; Electrocardiography; Enalapril; Hemodynamics; Hypertrophy, Left Ventricular; Myocardial Infarction; Systole; Time Factors; Ventricular Function, Left | 1995 |
[Mechanism of inhibition in left ventricular hypertrophy by captopril treatment in spontaneously hypertensive rats].
Topics: Animals; Captopril; Gene Expression; Genes, fos; Genes, myc; Hypertension; Hypertrophy, Left Ventricular; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 1995 |
Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen.
Topics: Animals; Captopril; Collagen; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage.
Topics: Animals; Captopril; Dogs; Hemodynamics; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Metoprolol; Myocardial Infarction; Random Allocation; Stroke Volume; Ventricular Function | 1994 |
Regression of cardiac hypertrophy and myosin isoenzyme patterns by losartan and captopril in renovascular hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardium; Myosins; Organ Size; Rats; Tetrazoles | 1994 |
Sympatholytic effect of captopril in regression of cardiovascular remodeling in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Clonidine; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Sympathetic Nervous System | 1994 |
[Regression of cardiac hypertrophy in hypertensive patients treated with captopril].
Topics: Adult; Captopril; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged | 1994 |
[Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
Topics: Action Potentials; Animals; Captopril; Drug Administration Schedule; Electrophysiology; Hemodynamics; Hydralazine; Hypertrophy, Left Ventricular; Myocardial Ischemia; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tachycardia, Ventricular | 1993 |
Left-ventricular hypertrophy in the spontaneously hypertensive rat: effect of ACE inhibitors on ultrastructural morphology.
Topics: Animals; Blood Pressure; Captopril; Cilazapril; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Microscopy, Electron; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Effects of captopril therapy after late reperfusion on left ventricular remodeling after experimental myocardial infarction.
Topics: Animals; Captopril; Cardiac Volume; Female; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Myocardial Infarction; Myocardial Reperfusion; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Pressure | 1994 |
[Left ventricular function in patients with arterial hypertension during the performance of acute drug tests with captopril and nifedipine].
Topics: Adult; Captopril; Drug Evaluation; Heart Function Tests; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine; Ventricular Function, Left | 1993 |
Effects of antihypertensive therapy on left ventricular hypertrophy of essential hypertension: a role for insulin-like growth factor I?
Topics: Adult; Aged; Antihypertensive Agents; Bisoprolol; Captopril; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Middle Aged; Regression Analysis | 1993 |
Beneficial effect of a novel diuretic, M17055, on blood pressure and cardiovascular hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Chemical Analysis; Blood Pressure; Captopril; Cardiomegaly; Diuretics; Hypertrophy, Left Ventricular; Male; Mesenteric Arteries; Organ Size; Oximes; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1993 |
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.
Topics: Animals; Captopril; Cardiac Pacing, Artificial; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Propranolol; Rats; Rats, Wistar; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 1994 |
More on the survival and ventricular enlargement trial.
Topics: Captopril; Electrocardiography; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Recurrence; Ventricular Function, Left | 1993 |
Effect of regression of cardiac hypertrophy on ischemic myocardial damage in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Hydralazine; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1993 |
Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure.
Topics: Animals; Blood Pressure; Captopril; Collagen; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Phenotype; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1993 |
[Left ventricular hypertrophy in spontaneously hypertensive rats: effect of angiotensin converting enzyme inhibitors on morphologic ultrastructure].
Topics: Animals; Captopril; Cilazapril; Dose-Response Relationship, Drug; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Male; Microscopy, Electron; Mitochondria, Heart; Myocardium; Rats; Rats, Inbred SHR; Rats, Wistar | 1993 |
Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiac Output; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Growth Hormone; Heart Failure; Heart Rate; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1995 |
Renal artery stenosis in infants: long-term medical treatment before surgery.
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension, Renal; Hypertrophy, Left Ventricular; Infant; Male; Renal Artery Obstruction; Retrospective Studies; Treatment Outcome; Urography; Vascular Surgical Procedures | 1996 |
Role of cardiac renin-angiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Blood Pressure; Body Weight; Captopril; Carotid Arteries; DNA; Female; Heart; Heart Ventricles; Hemodynamics; Hydralazine; Hypertrophy, Left Ventricular; Myocardium; Myosin Heavy Chains; Organ Size; Rats; Rats, Inbred Strains; Reference Values; Renin-Angiotensin System; RNA; Time Factors; Vasodilator Agents | 1996 |
Blood pressure and myocardial perfusion in hypertensive patients with and without left ventricular hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Captopril; Coronary Circulation; Heart; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Radiopharmaceuticals; Regression Analysis; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1995 |
Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Enzyme Inhibitors; Evaluation Studies as Topic; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Time Factors | 1996 |
Wall stress-induced arrhythmias in the working rat heart as left ventricular hypertrophy regresses during captopril treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Captopril; Heart; Hypertrophy, Left Ventricular; Male; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 1997 |
Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy.
Topics: Action Potentials; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Captopril; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Function | 1997 |
Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Dogs; Enalapril; Heart Ventricles; Hydroxyproline; Hypertrophy, Left Ventricular; Myocardial Infarction; Ultrasonography | 1997 |
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation.
Topics: Action Potentials; Animals; Captopril; Disease Models, Animal; Electrophysiology; Hypertrophy, Left Ventricular; Rabbits; Ventricular Fibrillation | 1997 |
[The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Drug Evaluation; Enalapril; Female; Glomerulonephritis; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Remission Induction; Time Factors | 1997 |
Changes in myocardial density during postinfarction healing: effect on estimation of in vivo left ventricular mass by echocardiographic imaging.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Female; Formaldehyde; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organ Size; Tissue Fixation; Ultrasonography | 1997 |
Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Leucine; Male; Muscle Proteins; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; RNA | 1997 |
Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Blood Pressure; Captopril; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypoxia; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Wistar | 1998 |
Effect of captopril on the development of left ventricular hypertrophy in rabbits with aortic insufficiency.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Body Weight; Captopril; Energy Metabolism; Hypertrophy, Left Ventricular; Male; Myocardium; Organ Size; Phosphorylation; Rabbits; RNA | 1997 |
Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits.
Topics: Action Potentials; Animals; Body Weight; Captopril; Cell Membrane; Cells, Cultured; Heart; Hypertrophy, Left Ventricular; Membrane Potentials; Nephrectomy; Organ Size; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rabbits; Renal Artery; Ventricular Function, Left | 1998 |
[Changes in the expression of alpha- and beta-myosin heavy chain gene during the development of renal hypertension in rats].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Gene Expression; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Myocardium; Myosin Heavy Chains; Rats; Rats, Sprague-Dawley | 1997 |
Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Captopril; Hypertension; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger | 1996 |
Inhibition of beta-myosin heavy chain gene expression in pressure overload rat heart by losartan and captopril.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Captopril; Gene Expression Regulation; Hypertrophy, Left Ventricular; Losartan; Male; Myosin Heavy Chains; Rats; Rats, Wistar; RNA, Messenger | 1997 |
Passive smoking induced hypertrophy of the left ventricle: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Hydroxyproline; Hypertrophy, Left Ventricular; Myocardium; Organ Size; Rabbits; Tobacco Smoke Pollution | 1999 |
Inhibitory effects of captopril on c-myc expression during left ventricular hypertrophy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Genes, myc; Hypertension; Hypertrophy, Left Ventricular; Male; Proto-Oncogene Proteins c-myc; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 1998 |
Modulation of adrenergic receptors during left ventricular hypertrophy development and after regression by captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Captopril; Disease Models, Animal; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta | 1999 |
Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Blood Pressure; Captopril; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Hypertrophy, Left Ventricular; Organ Size; Peptidyl-Dipeptidase A; Rats; Simvastatin; Time Factors | 1999 |
Effects of captopril treatment of renovascular hypertension on beta-adrenergic modulation of L-type Ca(2+) current.
Topics: Animals; Calcium Channels; Captopril; Colforsin; Dose-Response Relationship, Drug; Drug Interactions; Heart; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Isoproterenol; Nephrectomy; Patch-Clamp Techniques; Rabbits; Random Allocation; Receptors, Adrenergic, beta; Renal Artery; Time Factors | 2000 |
Improvement in fatty acid utilization in relation to a change in left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Fatty Acids; Hypertension; Hypertrophy, Left Ventricular; Male; Rats; Rats, Inbred SHR | 2000 |
Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Collagen; DNA; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Muscle Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Renin-Angiotensin System; RNA; Ventricular Remodeling | 2000 |
Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Endothelium, Vascular; Guinea Pigs; Hypertrophy, Left Ventricular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Substance P; Vasodilator Agents | 2000 |
Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Captopril; Collagen; Fibrosis; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Labetalol; Male; Myocardium; Nifedipine; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2000 |
Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Collagen; Fibrosis; Heart; Heart Ventricles; Hemodynamics; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Myosin Heavy Chains; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Tetrazoles | 2000 |
Changes in contractile protein gene expression with ageing and with captopril-induced regression of hypertrophy in the spontaneously hypertensive rats.
Topics: Actins; Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Gene Expression; Hypertrophy, Left Ventricular; In Situ Hybridization; Isomerism; Male; Muscle, Skeletal; Myocardium; Myosin Heavy Chains; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 2000 |
Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Body Weight; Captopril; Collagen; Constriction, Pathologic; Disease Models, Animal; Echocardiography; Hydroxyproline; Hypertrophy, Left Ventricular; In Vitro Techniques; Isoproterenol; Male; Myocardium; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Regression Analysis; Systole; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Captopril; Hypertrophy, Left Ventricular; Losartan; Male; Norepinephrine; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sympathetic Nervous System; Synapses; Vasoconstriction | 2000 |
Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cell Cycle; Cell Division; Cells, Cultured; Endothelium, Vascular; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Muscle, Smooth, Vascular; Phenotype; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Vasoconstriction | 2001 |
The Captopril Prevention Project, further analyses on left ventricular hypertrophy and diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypertrophy, Left Ventricular; Randomized Controlled Trials as Topic | 2001 |
Spatial and temporal analysis of left ventricular filling flow propagation in hypertensive patients before and after regression of myocardial hypertrophy with alacepril therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Captopril; Echocardiography, Doppler, Color; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Regression Analysis; Ventricular Function, Left | 2001 |
Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Heart; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging, Cine; Male; Myocardium; Organ Size; Rats; Rats, Wistar | 2002 |
Effect of captopril on urinary kallikrein, blood pressure and myocardial hypertrophy in diabetic spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kallikreins; Male; Rats; Rats, Inbred SHR | 2002 |
Captopril fails to reverse hypertrophy of the left ventricle induced by aortic insufficiency in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aortic Valve Insufficiency; Blood Pressure; Captopril; Chinchilla; Hydroxyproline; Hypertrophy, Left Ventricular; Male; Organ Size; Rabbits; Ventricular Remodeling | 2002 |
Evaluation of regression of left ventricular hypertrophy in hypertensive patients treated with captopril as assessed by magnetic resonance imaging.
Topics: Adult; Captopril; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Regression Analysis | 1992 |
[Regression of left ventricular hypertrophy in obese hypertensive patients treated with diet and pharmacologic therapy].
Topics: Captopril; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Obesity; Remission Induction | 1992 |
[Effects of captopril on left ventricular morphology and function in essential arterial hypertension].
Topics: Adult; Aged; Captopril; Diastole; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Ventricular Function, Left | 1992 |